上海(hai)百英生物(wu)科技股份有限(xian)公(gong)司(Biointron)成立于2012年,是(shi)一家(jia)專注(zhu)于抗體(ti)早期發現CRO服務的行業龍頭企業。公(gong)司通過了ISO9001:2015體(ti)系(xi)認證和兩化融合體(ti)系(xi)貫標,是(shi)國(guo)家(jia)高新技術企業、上海(hai)市科技小巨人企業。
百英(ying)生(sheng)物擁(yong)(yong)(yong)有(you)高通量重組抗(kang)體(ti)(ti)(ti)(ti)(ti)(ti)表達平(ping)(ping)(ping)臺(tai),單細(xi)胞(bao)抗(kang)體(ti)(ti)(ti)(ti)(ti)(ti)開(kai)發(fa)平(ping)(ping)(ping)臺(tai),利用微流控分(fen)選(xuan)與鑒定(ding)(ding)技(ji)術(shu),快速篩選(xuan)候選(xuan)分(fen)子(zi)。擁(yong)(yong)(yong)有(you)噬菌(jun)體(ti)(ti)(ti)(ti)(ti)(ti)庫抗(kang)體(ti)(ti)(ti)(ti)(ti)(ti)開(kai)發(fa)平(ping)(ping)(ping)臺(tai),全(quan)人源抗(kang)體(ti)(ti)(ti)(ti)(ti)(ti)庫、各種屬免疫庫等豐富的(de)建庫與淘選(xuan)經驗。擁(yong)(yong)(yong)有(you)羊駝(tuo)及(ji)(ji)鯊魚納米抗(kang)體(ti)(ti)(ti)(ti)(ti)(ti)開(kai)發(fa)平(ping)(ping)(ping)臺(tai),為雙抗(kang)研(yan)發(fa)、細(xi)胞(bao)治療提供(gong)(gong)支持。擁(yong)(yong)(yong)有(you)ECACC的(de)CHO-K1細(xi)胞(bao)株(zhu)全(quan)球(qiu)授權權利,可提供(gong)(gong)高表達穩定(ding)(ding)細(xi)胞(bao)株(zhu)的(de)開(kai)發(fa),PD小試工藝(yi)優化(hua)以及(ji)(ji)宿主細(xi)胞(bao)授權。擁(yong)(yong)(yong)有(you)抗(kang)體(ti)(ti)(ti)(ti)(ti)(ti)人源化(hua)、親和力(li)(li)成熟等抗(kang)體(ti)(ti)(ti)(ti)(ti)(ti)工程改造平(ping)(ping)(ping)臺(tai),以及(ji)(ji)全(quan)面的(de)藥效評(ping)價平(ping)(ping)(ping)臺(tai)。還擁(yong)(yong)(yong)有(you)大量現貨與活性驗證的(de)體(ti)(ti)(ti)(ti)(ti)(ti)內實(shi)驗用藥物通用抗(kang)體(ti)(ti)(ti)(ti)(ti)(ti)等產品。百英(ying)生(sheng)物致力(li)(li)于搭建一支行業領先(xian)的(de)高水(shui)平(ping)(ping)(ping)專(zhuan)業化(hua)團隊,力(li)(li)爭(zheng)(zheng)發(fa)展成為國際一流技(ji)術(shu)水(shui)平(ping)(ping)(ping)和全(quan)球(qiu)競爭(zheng)(zheng)力(li)(li)的(de)抗(kang)體(ti)(ti)(ti)(ti)(ti)(ti)發(fa)現CRO供(gong)(gong)應商,加速抗(kang)體(ti)(ti)(ti)(ti)(ti)(ti)藥物的(de)研(yan)發(fa)進程。